Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obesity
- Sponsor
- University of Ottawa
- Enrollment
- 68
- Locations
- 1
- Primary Endpoint
- Inspiratory Capacity during Exercise (L)
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Dyspnea is a common complaint in obese patients. The mechanisms behind this dyspnea and the effects of weight loss on dyspnea are not completely understood. The objectives of this study were to examine the relationships between exercise parameters and dyspnea in obesity and assess the effects of weight loss.
The investigators compared pulmonary function, exercise performance and dyspnea in 34 patients with abdominal obesity and metabolic syndrome (MS) against 34 age and sex-matched controls. The study also assessed within-group changes in physiology and symptoms in a subset of patients following participation in a weight management program.
Because obesity is a heterogeneous condition, with variable genetic associations, co-morbidities and distributions of adipose tissue, the study focused on patients with abdominal obesity who met diagnostic criteria for metabolic syndrome.
Detailed Description
The study has two parts: first, the investigators compared dyspnea, pulmonary function and exercise measurements between obese patients and control subjects with normal weight; then, the investigators assessed the effects of medical weight loss in the obese group on these parameters. Baseline dyspnea was assessed using the baseline dyspnea index.The effect of weight loss on dyspnea was assessed using the transitional dyspnea index. The main physiologic measurement of interest was the inspiratory capacity (L, measured at rest and during exercise).
Investigators
Dr. Nha Voduc
MD
University of Ottawa
Eligibility Criteria
Inclusion Criteria
- •Individuals accepted into the behavioural weight management program at the Ottawa Hospital Bariatric Centre
- •Age between 20 and 60 years
- •BMI greater than 30
- •Abdominal girth (for females) greater than 88 cm
- •Abdominal girth (for males) greater than 102 cm
- •Plus any two of the other criteria for Metabolic Syndrome:
- •i.e. Blood Pressure greater or equal to 130/85; Fasting Glucose greater or equal to 6.1 mmol/L
- •Controls-normal weight (NW) and sedentary
Exclusion Criteria
- •Any medical conditions which would affect exercise performance
- •Use of medications that could affect exercise performance (i.e. Beta-blockers)
- •Inability to pedal on a cycle ergometer and provide reproducible inspiratory capacity (IC) measurements
Outcomes
Primary Outcomes
Inspiratory Capacity during Exercise (L)
Time Frame: Within 6 months following completion of 6 month (weight loss period) in the weight management program
Inspiratory capacity measured at identical time points during incremental exercise tests, performed before and after weight loss
Dyspnea (measured by Transitional Dyspnea Index)
Time Frame: Within 6 months following completion of 6 months (weight loss period) in the weight management program
Dyspnea was assessed using a questionnaire based on the Transitional Dyspnea Index
Resting Inspiratory Capacity (L)
Time Frame: Within 6 months following completion of 6 months (weight loss period) in the weight management program
Inspiratory capacity (difference between total lung capacity and functional residual capacity), measured at rest